メタ情報
| meta description平均長 | 197.33 |
|---|
| OGPありページ数 | 5 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 116 |
|---|
| ページあたり内部リンク平均 | 47.56 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| can | 1 |
| thrombosis | 0.828144 |
| Source | 0.788709 |
| Function | 0.788709 |
| use | 0.788709 |
| Pharmacopoeia | 0.788709 |
| Standard | 0.788709 |
| treatment | 0.768991 |
| Extracted | 0.709838 |
| has | 0.591532 |
| Haoran | 0.562492 |
| male | 0.552096 |
| anticoagulant | 0.552096 |
| coagulation | 0.552096 |
| myocardial | 0.532379 |
| acute | 0.532379 |
| women | 0.532379 |
| embolism | 0.532379 |
| used | 0.473225 |
| sodium | 0.473225 |
| company | 0.446421 |
| pharmaceutical | 0.428571 |
| infarction | 0.414072 |
| promote | 0.414072 |
| blood | 0.394355 |
| sexual | 0.394355 |
| factor | 0.394355 |
| disease | 0.394355 |
| prevention | 0.394355 |
| quality | 0.392813 |
| gonadotropin | 0.380952 |
| which | 0.380952 |
| development | 0.37626 |
| our | 0.37626 |
| production | 0.362717 |
| ovulation | 0.354919 |
| urine | 0.333333 |
| drug | 0.333333 |
| established | 0.330878 |
| also | 0.330878 |
| high | 0.329227 |
| have | 0.315484 |
| Our | 0.315484 |
| service | 0.315484 |
| cerebral | 0.315484 |
| formation | 0.315484 |
| intestinal | 0.315484 |
| mucosa | 0.315484 |
| venous | 0.315484 |
| during | 0.315484 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Function | use | 3.299198 | 40 |
| Pharmacopoeia | Standard | 3.260045 | 38 |
| Extracted | Source | 3.143431 | 36 |
| Source | Standard | 2.966579 | 34 |
| over | world | 2.934815 | 33 |
| infarction | myocardial | 2.828064 | 28 |
| America | Australia | 2.79037 | 24 |
| America | Europe | 2.754237 | 26 |
| High | tech | 2.695074 | 24 |
| long | term | 2.636697 | 20 |
| intestinal | mucosa | 2.576 | 16 |
| Bio | Pharma | 2.550154 | 18 |
| over | supply | 2.489768 | 24 |
| Ltd | Pharma | 2.483947 | 17 |
| supply | will | 2.421749 | 24 |
| Road | Youkou | 2.378972 | 12 |
| area | square | 2.344964 | 12 |
| meters | square | 2.344964 | 12 |
| advantages | technical | 2.344964 | 12 |
| control | number | 2.344964 | 12 |
| number | technologies | 2.344964 | 12 |
| authorized | been | 2.344964 | 12 |
| invention | patents | 2.344964 | 12 |
| countries | regions | 2.344964 | 12 |
| Bio | Ltd | 2.340381 | 17 |
| Pharmacopoeia | Source | 2.292042 | 25 |
| thrombosis | vein | 2.278683 | 22 |
| Europe | such | 2.262502 | 24 |
| Extracted | Standard | 2.210724 | 23 |
| Development | Zone | 2.203159 | 12 |
| core | formed | 2.203159 | 12 |
| core | technical | 2.203159 | 12 |
| degraded | mucosa | 2.203159 | 12 |
| angina | unstable | 2.203159 | 12 |
| angina | non | 2.193555 | 11 |
| embolism | pulmonary | 2.191103 | 16 |
| high | quality | 2.166787 | 37 |
| Bio | Haoran | 2.144946 | 23 |
| Enoxaparin | Sodium | 2.141571 | 16 |
| Australia | Europe | 2.140941 | 18 |
| product | will | 2.132387 | 24 |
| area | covers | 2.093166 | 12 |
| deep | vein | 2.093166 | 12 |
| gonadotropin | urinary | 2.082702 | 14 |
| more | than | 2.061354 | 12 |
| API | workshop | 2.058435 | 11 |
| Since | establishment | 2.036853 | 10 |
| such | world | 2.035235 | 24 |
| Nanchang | Zone | 2.025344 | 14 |
| Pioneer | Workers | 2.0224 | 8 |